Perfect adaptation of CD8+ T cell responses to constant antigen input over a wide range of affinity is overcome by costimulation

Maintaining and limiting T cell responses to constant antigen stimulation is critical to control pathogens and maintain self-tolerance, respectively. Antigen recognition by T cell receptors (TCRs) induces signalling that activates T cells to produce cytokines and also leads to the downregulation of surface TCRs. In other systems, receptor downregulation can induce perfect adaptation to constant stimulation by a mechanism known as state-dependent inactivation that requires complete downregulation of the receptor or the ligand. However, this is not the case for the TCR, and therefore, precisely how TCR downregulation maintains or limits T cell responses is controversial. Here, we observed that in vitro expanded primary human T cells exhibit perfect adaptation in cytokine production to constant antigen stimulation across a 100,000-fold variation in affinity with partial TCR downregulation. By directly fitting a mechanistic model to the data, we show that TCR downregulation produces imperfect adaptation, but when coupled to a switch produces perfect adaptation in cytokine production. A pre-diction of the model is that pMHC-induced TCR signalling continues after adaptation and this is confirmed by showing that, while costimulation cannot prevent adaptation, CD28 and 4-1BB signalling reactivated adapted T cells to produce cytokines in a pMHC-dependent manner. We show that adaptation also applied to 1st generation chimeric antigen receptor (CAR)-T cells but is partially avoided in 2nd generation CARs. These findings high-light that even partial TCR downregulation can limit T cell responses by producing perfect adaptation rendering T cells dependent on costimulation for sustained responses.

[1]  Omer Dushek,et al.  Molecular mechanisms of T cell sensitivity to antigen , 2018, Immunological reviews.

[2]  Balbino Alarcón,et al.  Cell Biology of T Cell Receptor Expression and Regulation. , 2018, Annual review of immunology.

[3]  Omkar U. Kawalekar,et al.  CAR T cell immunotherapy for human cancer , 2018, Science.

[4]  P. Greenberg,et al.  Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains , 2018, The Journal of Immunology.

[5]  B. Kwon,et al.  Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression , 2018, Nature Communications.

[6]  A. Kamphorst,et al.  CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. , 2018, Annual review of medicine.

[7]  Peter K. Sorger,et al.  Receptor-Based Mechanism of Cell Memory and Relative Sensing in Mammalian Signaling Networks , 2017, bioRxiv.

[8]  Geoff P. O’Donoghue,et al.  Early T cell receptor signals globally modulate ligand:receptor affinities during antigen discrimination , 2017, Proceedings of the National Academy of Sciences.

[9]  N. Paolini,et al.  Distinct PKC-mediated posttranscriptional events set cytokine production kinetics in CD8+ T cells , 2017, Proceedings of the National Academy of Sciences.

[10]  Eduardo D. Sontag,et al.  Oscillatory stimuli differentiate adapting circuit topologies , 2017, Nature Methods.

[11]  L. Varani,et al.  Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Koichi Araki,et al.  Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent , 2016, Science.

[13]  Mithat Gönen,et al.  Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection , 2017, Nature.

[14]  J. Wolchok,et al.  An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity , 2017, Molecular therapy oncolytics.

[15]  Omer Dushek,et al.  Architecture of a minimal signaling pathway explains the T-cell response to a 1 million-fold variation in antigen affinity and dose , 2016, Proceedings of the National Academy of Sciences.

[16]  Michael Loran Dustin,et al.  What Scales the T Cell Response? , 2016, Trends in immunology.

[17]  É. Vivier,et al.  The discontinuity theory of immunity , 2016, Science Immunology.

[18]  James E Ferrell,et al.  Perfect and Near-Perfect Adaptation in Cell Signaling. , 2016, Cell systems.

[19]  M. Glickman,et al.  Control of T cell antigen reactivity via programmed TCR downregulation , 2015, Nature Immunology.

[20]  M. Sadelain,et al.  Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells. , 2015, Cancer cell.

[21]  A. Heimberger,et al.  Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity. , 2015, Cancer research.

[22]  J. E. Brewer,et al.  NY-ESO-1 specific TCR engineered T-cells mediate sustained antigen-specific antitumor effects in myeloma , 2015, Nature Medicine.

[23]  J. E. Brewer,et al.  T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells , 2015, Clinical and experimental immunology.

[24]  D. Cantrell,et al.  Protein kinase D2 is a digital amplifier of T cell receptor–stimulated diacylglycerol signaling in naïve CD8+ T cells , 2014, Science Signaling.

[25]  Omer Dushek,et al.  Phenotypic models of T cell activation , 2014, Nature Reviews Immunology.

[26]  Cheng Zhu,et al.  Accumulation of Dynamic Catch Bonds between TCR and Agonist Peptide-MHC Triggers T Cell Signaling , 2014, Cell.

[27]  Omer Dushek,et al.  An induced rebinding model of antigen discrimination☆ , 2014, Trends in immunology.

[28]  Ronald N Germain,et al.  Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues. , 2014, Immunity.

[29]  Mark M Davis,et al.  A single peptide-major histocompatibility complex ligand triggers digital cytokine secretion in CD4(+) T cells. , 2013, Immunity.

[30]  M. van den Broek,et al.  Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system. , 2013, Anticancer research.

[31]  Lieping Chen,et al.  Molecular mechanisms of T cell co-stimulation and co-inhibition , 2013, Nature Reviews Immunology.

[32]  Edward Y Kim,et al.  The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cells. , 2013, Immunity.

[33]  Paul François,et al.  Phenotypic model for early T-cell activation displaying sensitivity, specificity, and antagonism , 2013, Proceedings of the National Academy of Sciences.

[34]  Omer Dushek,et al.  Non‐catalytic tyrosine‐phosphorylated receptors , 2012, Immunological reviews.

[35]  Douglas A. Lauffenburger,et al.  Polyfunctional responses by human T cells result from sequential release of cytokines , 2011, Proceedings of the National Academy of Sciences.

[36]  B. Jakobsen,et al.  Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen. , 2011, Blood.

[37]  Daniel Coombs,et al.  Antigen Potency and Maximal Efficacy Reveal a Mechanism of Efficient T Cell Activation , 2011, Science Signaling.

[38]  Hao Liu,et al.  CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. , 2011, The Journal of clinical investigation.

[39]  R. Obst,et al.  Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery , 2010, Proceedings of the National Academy of Sciences.

[40]  R. Nurieva,et al.  The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. , 2010, Immunity.

[41]  P. Greenberg,et al.  Mathematical Modeling of Chimeric TCR Triggering Predicts the Magnitude of Target Lysis and Its Impairment by TCR Downmodulation , 2010, The Journal of Immunology.

[42]  Daniel Coombs,et al.  Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time , 2010, Immunity.

[43]  Naama Brenner,et al.  Adaptive response by state-dependent inactivation , 2009, Proceedings of the National Academy of Sciences.

[44]  Raibatak Das,et al.  A Role for Rebinding in Rapid and Reliable T Cell Responses to Antigen , 2009, PLoS Comput. Biol..

[45]  W. Lim,et al.  Defining Network Topologies that Can Achieve Biochemical Adaptation , 2009, Cell.

[46]  N. Müller,et al.  Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand1 , 2009, The Journal of Immunology.

[47]  A. Wells New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting , 2009, The Journal of Immunology.

[48]  V. Cerundolo,et al.  Rational development of high-affinity T-cell receptor-like antibodies , 2009, Proceedings of the National Academy of Sciences.

[49]  G. Koretzky,et al.  T cell activation. , 2009, Annual review of immunology.

[50]  I. Pastan,et al.  Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains , 2009, Proceedings of the National Academy of Sciences.

[51]  Jayajit Das,et al.  Digital Signaling and Hysteresis Characterize Ras Activation in Lymphoid Cells , 2009, Cell.

[52]  David Welch,et al.  Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems , 2009, Journal of The Royal Society Interface.

[53]  A. Chakraborty,et al.  The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality. , 2008, Immunity.

[54]  P. Greenberg,et al.  Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor. , 2008, Immunity.

[55]  S. Larson,et al.  Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts , 2007, Clinical Cancer Research.

[56]  H. Steven Wiley,et al.  Cell Surface Receptors for Signal Transduction and Ligand Transport: A Design Principles Study , 2007, PLoS Comput. Biol..

[57]  Daniel Coombs,et al.  Analysis of peptide/MHC-induced TCR downregulation , 2007, Cell Biochemistry and Biophysics.

[58]  R. Schwartz,et al.  Adaptive Tolerance and Clonal Anergy Are Distinct Biochemical States1 , 2006, The Journal of Immunology.

[59]  R. Matusik,et al.  Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells , 2006, Immunology.

[60]  H. Heslop,et al.  A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[61]  Ronald N Germain,et al.  Modeling T Cell Antigen Discrimination Based on Feedback Control of Digital ERK Responses , 2005, PLoS biology.

[62]  S. Anderton,et al.  Fas‐mediated death and sensory adaptation limit the pathogenic potential of autoreactive T cells after strong antigenic stimulation , 2005, Journal of leukocyte biology.

[63]  Yi Li,et al.  Directed evolution of human T-cell receptors with picomolar affinities by phage display , 2005, Nature Biotechnology.

[64]  B. Alarcón,et al.  Engaged and Bystander T Cell Receptors Are Down-modulated by Different Endocytotic Pathways* , 2004, Journal of Biological Chemistry.

[65]  J. Penninger,et al.  Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. , 2004, Immunity.

[66]  M. Nussenzweig,et al.  Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. , 2004, Immunity.

[67]  Oreste Acuto,et al.  CD28-mediated co-stimulation: a quantitative support for TCR signalling , 2003, Nature Reviews Immunology.

[68]  Arup K Chakraborty,et al.  The Immunological Synapse Balances T Cell Receptor Signaling and Degradation , 2003, Science.

[69]  R. Schwartz,et al.  The Strength of Persistent Antigenic Stimulation Modulates Adaptive Tolerance in Peripheral CD4+ T Cells , 2003, The Journal of experimental medicine.

[70]  D. Kioussis,et al.  Chronic Exposure to Low Levels of Antigen in the Periphery Causes Reversible Functional Impairment Correlating with Changes in CD5 Levels in Monoclonal CD8 T Cells , 2003, The Journal of Immunology.

[71]  M. Naramura,et al.  c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation , 2002, Nature Immunology.

[72]  Anjana Rao,et al.  Transcriptional Mechanisms Underlying Lymphocyte Tolerance , 2002, Cell.

[73]  P. S. Andersen,et al.  The CD3γ Leucine-Based Receptor-Sorting Motif Is Required for Efficient Ligand-Mediated TCR Down-Regulation1 , 2002, The Journal of Immunology.

[74]  O. Acuto,et al.  CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. , 2001, Immunity.

[75]  M. Purbhoo,et al.  Sensory Adaptation in Naive Peripheral CD4 T Cells , 2001, The Journal of experimental medicine.

[76]  S. Bromley,et al.  The immunological synapse. , 2001, Annual review of immunology.

[77]  J. Carneiro,et al.  A mathematical analysis of TCR serial triggering and down‐regulation , 2000, European journal of immunology.

[78]  V. Cerundolo,et al.  Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL1 , 2000, The Journal of Immunology.

[79]  K. Bachmaier Regulation of autoimmunity by the molecular adaptor Cbl-b , 2000 .

[80]  B. Alarcón,et al.  Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism. , 2000, Immunity.

[81]  H. Nishina,et al.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b , 2000, Nature.

[82]  M. Jackson,et al.  TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. , 1999, Science.

[83]  G. Freeman,et al.  Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands. , 1999, International immunology.

[84]  M. Naramura,et al.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[85]  M. Bevan,et al.  Transient alteration of T cell fine specificity by a strong primary stimulus correlates with T cell receptor down‐regulation , 1998, European journal of immunology.

[86]  D. Bowtell,et al.  Tissue Hyperplasia and Enhanced T-Cell Signalling via ZAP-70 in c-Cbl-Deficient Mice , 1998, Molecular and Cellular Biology.

[87]  A. Lanzavecchia,et al.  The duration of antigenic stimulation determines the fate of naive and effector T cells. , 1998, Immunity.

[88]  A. Lanzavecchia,et al.  Agonist‐induced T cell receptor down‐regulation: molecular requirements and dissociation from T cell activation , 1997, European journal of immunology.

[89]  M. Jackson,et al.  Requirements for Peptide-induced T Cell Receptor Downregulation on Naive CD8+ T Cells , 1997, The Journal of experimental medicine.

[90]  Antonio Lanzavecchia,et al.  T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.

[91]  J. Alferink,et al.  T Cell Awareness of Paternal Alloantigens During Pregnancy , 1995, Science.

[92]  K. Takase,et al.  [T cell activation]. , 1995, Ryumachi. [Rheumatism].

[93]  T. McKeithan,et al.  Kinetic proofreading in T-cell receptor signal transduction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[94]  A. Lanzavecchia,et al.  Serial triggering of many T-cell receptors by a few peptide–MHC complexes , 1995, Nature.

[95]  G. Schönrich,et al.  Levels of peripheral T cell tolerance induced by different doses of tolerogen. , 1994, Science.

[96]  R. Schwartz T cell anergy. , 2003, Annual review of immunology.

[97]  Z. Grossman,et al.  Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[98]  G. Schönrich,et al.  Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction , 1991, Cell.

[99]  J. Lamb,et al.  Tolerance of T-cell clones is associated with membrane antigen changes , 1983, Nature.

[100]  E. Reinherz,et al.  Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex , 1982, Cell.